Range
24.44 - 25.66
Vol / Avg.
1.4M/1.7M
Div / Yield
-
52 Wk
15.88 - 54.21
Mkt Cap
3.9B
Payout Ratio
-
Open
25.31
P/E
-
EPS
-0.53
Shares
155M
Outstanding
155M
Total Float
129.9M
load more
Sector: Health Care.Industry: Biotechnology
Iovance Biotherapeutics Inc is a clinical-stage biopharmaceutical company. The company focused on the development and commercialization of cell therapies as novel cancer immunotherapy products designed to harness the power of a patient's immune system to eradicate cancer cells. It's lead pipeline candidate, LN-145, is an adoptive cell therapy using tumor-infiltrating lymphocytes (TIL) to treat patients with refractory metastatic melanoma.

Earnings

see more
Q3 2021Est.ActualSurprise
EPS
(EXPECTED)2021-11-04
REV
Q2 2021Est.ActualSurprise
EPS-0.510-0.530 -0.0200
REV0

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target

Related Companies

TickerCompanyChg %Mkt Cap
IOVAIovance Biotherapeutics-2.5%3.9B

Iovance Biotherapeutics Questions & Anwsers

Q

How do I buy Iovance Biotherapeutics (IOVA) stock?

A

You can purchase shares of Iovance Biotherapeutics (NASDAQ: IOVA) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Iovance Biotherapeutics's (IOVA) competitors?

Q

What is the target price for Iovance Biotherapeutics (IOVA) stock?

A

The latest price target for Iovance Biotherapeutics (NASDAQ: IOVA) was reported by Oppenheimer on May 24, 2021. The analyst firm set a price target for 38.00 expecting IOVA to rise to within 12 months (a possible 52.24% upside). 16 analyst firms have reported ratings in the last year.

Q

Current Stock Price for Iovance Biotherapeutics (IOVA)?

A

The stock price for Iovance Biotherapeutics (NASDAQ: IOVA) is $24.96 last updated Fri Sep 24 2021 20:00:02 GMT+0000 (Coordinated Universal Time).

Q

Does Iovance Biotherapeutics (IOVA) pay a dividend?

A

There are no upcoming dividends for Iovance Biotherapeutics.

Q

When is Iovance Biotherapeutics (NASDAQ:IOVA) reporting earnings?

A
Iovance Biotherapeutics’s Q3 earnings are confirmed for after-market on November 4, 2021.
Q

Is Iovance Biotherapeutics (IOVA) going to split?

A

There is no upcoming split for Iovance Biotherapeutics.

Q

What sector and industry does Iovance Biotherapeutics (IOVA) operate in?

A

Iovance Biotherapeutics is in the Consumer Discretionary sector and Multiline Retail industry. They are listed on the NASDAQ.